LAMEA Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The Latin America, Middle East and Africa Muscle Relaxant Drugs Market would witness market growth of 6.2% CAGR during the forecast period (2023-2029).

The number of fibromyalgia (FM) research articles has significantly expanded over the last few decades. This increase may be attributed to heightened awareness and common interest among a number of stakeholders, including the pharmaceutical business, patient self-help organizations, clinicians, and researchers. In addition to encouraging research to understand the underlying pathophysiology better and enhance therapy, this designation of FM will also encourage using muscle relaxants to lessen the amount of discomfort experienced by FM patients.

The rising demand for muscle relaxant treatments in the cosmetic industry and increased online sales of these medications are the primary trends that can be seen in the market for these medications. Many retailers and pharmaceutical companies have made muscle relaxant medications accessible to the public online. Online retailing has been a significant trend in the market since it makes drugs more accessible, saves time, and is more convenient while offering cheaper pricing.

Israel's population is aging more quickly than the average, much like in many other countries throughout the world. The proportion of adults 65 and older has increased by 18 since 1950. The overall population of Israel is expected to reach 12.1 million by 2035, with seniors making up roughly 14% of the total, or 1.9 million people. Only 4% of people were 65 and older in 1948 when the State of Israel was established. Over time, there has been constant growth in this population. Life expectancy has risen by 1% annually since 1995, which is expected to continue. As muscle pain-related problems are more common in older people, demand is projected to rise, spurring market expansion in LAMEA.

The Brazil market dominated the LAMEA Muscle Relaxant Drugs Market by Country in 2022 thereby, achieving a market value of $81.5 Million by 2029. The Argentina market is showcasing a CAGR of 6.8% during (2023 - 2029). Additionally, The UAE market would register a CAGR of 5.9% during (2023 - 2029).

Based on Drug Type, the market is segmented into Skeletal, Neuromuscular Blocking Agents and Facial Muscle Relaxant Drugs. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Amneal Pharmaceuticals, Inc., Ipsen Pharma Biotech SAS, Merz Pharma GmbH & Co. KGaA, Mallinckrodt PLC, Teva Pharmaceuticals Industries Ltd., Eisai Co., Ltd., Endo International PLC, Vertical Pharmaceuticals, LLC, SteriMax Inc., and Metacel Pharmaceuticals, LLC.

Scope of the Study

Market Segments covered in the Report:

By Drug Type

Skeletal
Neuromuscular Blocking Agents
Facial Muscle Relaxant Drugs

By Route of Administration

Oral
Injectable

By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacies

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Companies Profiled

Amneal Pharmaceuticals, Inc.
Ipsen Pharma Biotech SAS
Merz Pharma GmbH & Co. KGaA
Mallinckrodt PLC
Teva Pharmaceuticals Industries Ltd.
Eisai Co., Ltd.
Endo International PLC
Vertical Pharmaceuticals, LLC
SteriMax Inc.
Metacel Pharmaceuticals, LLC

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Muscle Relaxant Drugs Market, by Drug Type
- 1.4.2 LAMEA Muscle Relaxant Drugs Market, by Route of Administration
- 1.4.3 LAMEA Muscle Relaxant Drugs Market, by Distribution Channel
- 1.4.4 LAMEA Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. LAMEA Muscle Relaxant Drugs Market by Drug Type

3.1 LAMEA Skeletal Market by Country
3.2 LAMEA Neuromuscular Blocking Agents Market by Country
3.3 LAMEA Facial Muscle Relaxant Drugs Market by Country

Chapter 4. LAMEA Muscle Relaxant Drugs Market by Route of Administration

4.1 LAMEA Oral Market by Country
4.2 LAMEA Injectable Market by Country

Chapter 5. LAMEA Muscle Relaxant Drugs Market by Distribution Channel

5.1 LAMEA Hospital Pharmacy Market by Country
5.2 LAMEA Retail Pharmacy Market by Country
5.3 LAMEA Online Pharmacies Market by Country

Chapter 6. LAMEA Muscle Relaxant Drugs Market by Country

6.1 Brazil Muscle Relaxant Drugs Market
- 6.1.1 Brazil Muscle Relaxant Drugs Market by Drug Type
- 6.1.2 Brazil Muscle Relaxant Drugs Market by Route of Administration
- 6.1.3 Brazil Muscle Relaxant Drugs Market by Distribution Channel
6.2 Argentina Muscle Relaxant Drugs Market
- 6.2.1 Argentina Muscle Relaxant Drugs Market by Drug Type
- 6.2.2 Argentina Muscle Relaxant Drugs Market by Route of Administration
- 6.2.3 Argentina Muscle Relaxant Drugs Market by Distribution Channel
6.3 UAE Muscle Relaxant Drugs Market
- 6.3.1 UAE Muscle Relaxant Drugs Market by Drug Type
- 6.3.2 UAE Muscle Relaxant Drugs Market by Route of Administration
- 6.3.3 UAE Muscle Relaxant Drugs Market by Distribution Channel
6.4 Saudi Arabia Muscle Relaxant Drugs Market
- 6.4.1 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type
- 6.4.2 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration
- 6.4.3 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel
6.5 South Africa Muscle Relaxant Drugs Market
- 6.5.1 South Africa Muscle Relaxant Drugs Market by Drug Type
- 6.5.2 South Africa Muscle Relaxant Drugs Market by Route of Administration
- 6.5.3 South Africa Muscle Relaxant Drugs Market by Distribution Channel
6.6 Nigeria Muscle Relaxant Drugs Market
- 6.6.1 Nigeria Muscle Relaxant Drugs Market by Drug Type
- 6.6.2 Nigeria Muscle Relaxant Drugs Market by Route of Administration
- 6.6.3 Nigeria Muscle Relaxant Drugs Market by Distribution Channel
6.7 Rest of LAMEA Muscle Relaxant Drugs Market
- 6.7.1 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type
- 6.7.2 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration
- 6.7.3 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel

Chapter 7. Company Profiles

7.1 Amneal Pharmaceuticals, Inc.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental Analysis
- 7.1.4 Research & Development Expenses
- 7.1.5 Recent strategies and developments:
  - 7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expense
- 7.2.5 Recent strategies and developments:
  - 7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
- 7.3.1 Company Overview
7.4 Mallinckrodt PLC
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental and Regional Analysis
- 7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional Analysis
- 7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expenses
7.7 Endo International PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental Analysis
- 7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
- 7.8.1 Company Overview
7.9 SteriMax Inc.
- 7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
- 7.10.1 Company Overview

LIST OF TABLES

TABLE 1 LAMEA Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 3 LAMEA Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 LAMEA Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 5 LAMEA Skeletal Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Skeletal Market by Country, 2023 - 2029, USD Million
TABLE 7 LAMEA Neuromuscular Blocking Agents Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Neuromuscular Blocking Agents Market by Country, 2023 - 2029, USD Million
TABLE 9 LAMEA Facial Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Facial Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 11 LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 12 LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 13 LAMEA Oral Market by Country, 2019 - 2022, USD Million
TABLE 14 LAMEA Oral Market by Country, 2023 - 2029, USD Million
TABLE 15 LAMEA Injectable Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Injectable Market by Country, 2023 - 2029, USD Million
TABLE 17 LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 19 LAMEA Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Hospital Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 21 LAMEA Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 LAMEA Retail Pharmacy Market by Country, 2023 - 2029, USD Million
TABLE 23 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 LAMEA Muscle Relaxant Drugs Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Muscle Relaxant Drugs Market by Country, 2023 - 2029, USD Million
TABLE 27 Brazil Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 28 Brazil Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 29 Brazil Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 Brazil Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 31 Brazil Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 32 Brazil Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 33 Brazil Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 Brazil Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 35 Argentina Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 36 Argentina Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 37 Argentina Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 38 Argentina Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 39 Argentina Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 40 Argentina Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 41 Argentina Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Argentina Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 43 UAE Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 44 UAE Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 45 UAE Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 46 UAE Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 47 UAE Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 48 UAE Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 49 UAE Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 UAE Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 51 Saudi Arabia Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 52 Saudi Arabia Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 53 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 Saudi Arabia Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 55 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 57 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 59 South Africa Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 60 South Africa Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 61 South Africa Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 62 South Africa Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 63 South Africa Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 64 South Africa Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 65 South Africa Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 66 South Africa Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 67 Nigeria Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 68 Nigeria Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 69 Nigeria Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 70 Nigeria Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 71 Nigeria Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 72 Nigeria Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 73 Nigeria Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 74 Nigeria Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 75 Rest of LAMEA Muscle Relaxant Drugs Market, 2019 - 2022, USD Million
TABLE 76 Rest of LAMEA Muscle Relaxant Drugs Market, 2023 - 2029, USD Million
TABLE 77 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type, 2019 - 2022, USD Million
TABLE 78 Rest of LAMEA Muscle Relaxant Drugs Market by Drug Type, 2023 - 2029, USD Million
TABLE 79 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2023 - 2029, USD Million
TABLE 81 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 83 Key Information - Amneal Pharmaceuticals, INc.
TABLE 84 Key Information - Ipsen Pharma Biotech SAS
TABLE 85 Key information - Merz Pharma GmbH & Co. KGaA
TABLE 86 Key information - Mallinckrodt PLC
TABLE 87 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 88 Key Information - Eisai Co., Ltd.
TABLE 89 Key Information - Endo International PLC
TABLE 90 Key Information - Vertical Pharmaceuticals, LLC
TABLE 91 Key Information - SteriMax Inc.
TABLE 92 Key Information - Metacel Pharmaceuticals, LLC.

List of Figures

FIG 1 Methodology for the research
FIG 2 LAMEA Muscle Relaxant Drugs Market Share by Drug Type, 2022
FIG 3 LAMEA Muscle Relaxant Drugs Market Share by Drug Type, 2029
FIG 4 LAMEA Muscle Relaxant Drugs Market by Drug Type, 2019 - 2029, USD Million
FIG 5 LAMEA Muscle Relaxant Drugs Market Share by Route of Administration, 2022
FIG 6 LAMEA Muscle Relaxant Drugs Market Share by Route of Administration, 2029
FIG 7 LAMEA Muscle Relaxant Drugs Market by Route of Administration, 2019 - 2029, USD Million
FIG 8 LAMEA Muscle Relaxant Drugs Market Share by Distribution Channel, 2022
FIG 9 LAMEA Muscle Relaxant Drugs Market Share by Distribution Channel, 2029
FIG 10 LAMEA Muscle Relaxant Drugs Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 LAMEA Muscle Relaxant Drugs Market Share by Country, 2022
FIG 12 LAMEA Muscle Relaxant Drugs Market Share by Country, 2029
FIG 13 LAMEA Muscle Relaxant Drugs Market by Country, 2019 - 2029, USD Million

LAMEA Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

Description

Table of Contents